GuiZhou SanLi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -6.58% vs -2.11% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 6.12% vs -25.31% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "381.70",
          "val2": "408.60",
          "chgp": "-6.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.40",
          "val2": "66.60",
          "chgp": "-19.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.70",
          "val2": "3.10",
          "chgp": "51.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "45.10",
          "val2": "42.50",
          "chgp": "6.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "140.00%",
          "val2": "116.40%",
          "chgp": "2.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 31.08% vs 36.05% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,125.80",
          "val2": "1,621.70",
          "chgp": "31.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "400.50",
          "val2": "307.00",
          "chgp": "30.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.60",
          "val2": "4.20",
          "chgp": "247.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "279.80",
          "val2": "294.90",
          "chgp": "-5.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "152.60%",
          "val2": "166.10%",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

381.70

408.60

-6.58%

Operating Profit (PBDIT) excl Other Income

53.40

66.60

-19.82%

Interest

4.70

3.10

51.61%

Exceptional Items

0.00

0.00

Consolidate Net Profit

45.10

42.50

6.12%

Operating Profit Margin (Excl OI)

140.00%

116.40%

2.36%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -6.58% vs -2.11% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 6.12% vs -25.31% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

2,125.80

1,621.70

31.08%

Operating Profit (PBDIT) excl Other Income

400.50

307.00

30.46%

Interest

14.60

4.20

247.62%

Exceptional Items

0.10

-0.00

Consolidate Net Profit

279.80

294.90

-5.12%

Operating Profit Margin (Excl OI)

152.60%

166.10%

-1.35%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 31.08% vs 36.05% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -5.12% vs 53.67% in Dec 2023

All Annual Results